Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus
Evidence in Focus, February 2022
Read Published ArticleRetired on February 8, 2025.
Questions?
Email guidelines@aan.com
Call (800) 879-1960 or (612) 928-6000 (international)